Three researchers from the Virginia Bioinformatics Institute (VBI) at Virginia Tech have developed and evaluated a new one-step bioanalytical approach that allows them to profile in detail complex cellular extracts of proteins. The method has allowed the scientists to look at how the levels of proteins change in breast cancer cells when they are treated with hormones or cancer drugs like tamoxifen.

A new study finds that many women with breast cancer take antioxidant supplements while undergoing cancer treatment, even though the consequences of doing so are unknown. Published in the July 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that additional research should be undertaken to determine the effects of antioxidant supplementation on the health and survival of breast cancer patients.

Hannah Powell-Auslam, is a rarity, and not in a good way. In fact, she is one of few children to be diagnosed with breast cancer; she is only 10 years old and she is already fighting it. Statistics say 1 in 8 women will face breast cancer, but in terms of children, it would be 1 in 12 million.

If having malodorous armpits (called osmidrosis) and goopy earwax isn't bad enough, a discovery by Japanese scientists may add a more serious problem for women facing these cosmetic calamities. That's because they've found that a gene responsible for breast cancer causes these physical symptoms.

A new study finds that nearly one in four African American women with late stage breast cancer refused chemotherapy and radiation therapy, potentially life saving therapies. Published in the July 1, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that more efforts are needed to ensure that all women with breast cancer receive appropriate care.

Although a test for gene mutations known to significantly increase the risk of hereditary breast or ovarian cancer has been available for more than a decade, a new study finds that few women with family histories of these cancers are even discussing genetic testing with their physicians or other health care providers.

The risk of developing breast cancer due to taking hormone replacement therapy appears to be the same for women with a family history of breast cancer and without a family history, a University of Rochester Medical Center study concluded.

Pathfinders, a program designed to care for the whole person -- body, mind and spirit -- has been found to help women with terminal breast cancer cope and improved their quality of life, according to a study led by researchers in the Duke Comprehensive Cancer Center.

Scientists at Albert Einstein College of Medicine of Yeshiva University have discovered how a gene crucial in triggering the spread of breast cancer is turned on and off. The findings could help predict whether breast tumors will metastasize and also reveal potential drug targets for preventing breast cancer metastasis. The study will appear in the May 20th online edition of the Journal of Cell Science.

A new phase III clinical trial of early stage breast cancer patients has shown that a molecule designed to home in on nearby lymph nodes is just as accurate as current techniques, but faster, more specific and easier to use.

Reporting online in the American Journal of Pathology, researchers from the Kimmel Cancer Center at Jefferson have implicated the loss of a stromal protein called caveolin-1 as a major new prognostic factor in patients with breast cancer, predicting early disease recurrence, metastasis and breast cancer patient survival.

3T MRI, a powerful tool for evaluating patients with a high risk of having breast cancer, can detect a significant number of breast cancer lesions not found on mammography and sonography, according to a study performed at the University of Toledo Medical Center, Toledo, OH.